Suppr超能文献

我们中间的冠军:引领初级保健走向阿片类药物使用障碍治疗的前沿。

Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment.

机构信息

Division of General Internal Medicine, University of Utah, Salt Lake City, USA.

Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, USA.

出版信息

J Gen Intern Med. 2022 May;37(7):1771-1773. doi: 10.1007/s11606-021-07355-7. Epub 2022 Jan 11.

Abstract

Despite more than a decade of investment in opioid use disorder (OUD) treatment infrastructure, the year 2020 saw the highest mortality related to opioid overdose in American history. Treatment access remains critically limited, with less than half of people living with OUD receiving any treatment. Primary care has been referred to as the "sleeping giant" of addiction care, as few primary care doctors currently prescribe medications to treat OUD. The "clinical champions" framework is a tool that has shown promise in creating the type of mentorship and culture change necessary to expand uptake of medication-based OUD treatment among primary care providers. The early success of this model and the increased availability of tools for broad implementation warrant further investment as a means of leading primary care into a larger role in combatting the opioid addiction epidemic.

摘要

尽管在阿片类药物使用障碍(OUD)治疗基础设施方面投入了十余年,但 2020 年美国因阿片类药物过量而导致的死亡率却创下历史最高纪录。治疗的可及性仍然严重受限,只有不到一半的 OUD 患者接受任何治疗。初级保健被称为“成瘾治疗的沉睡巨人”,因为目前很少有初级保健医生开处药物来治疗 OUD。“临床冠军”框架是一种有前途的工具,可以为扩大初级保健提供者对基于药物的 OUD 治疗的接受度创造必要的指导和文化变革。该模式的早期成功以及更广泛应用工具的可用性,需要进一步投资,以此引导初级保健在对抗阿片类药物成瘾流行方面发挥更大作用。

相似文献

引用本文的文献

本文引用的文献

5
Cost-effectiveness of Treatments for Opioid Use Disorder.阿片类药物使用障碍治疗的成本效益。
JAMA Psychiatry. 2021 Jul 1;78(7):767-777. doi: 10.1001/jamapsychiatry.2021.0247.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验